Rocky Mountain Laboratories

CLIA Laboratory Citation Details

3
Total Citations
37
Total Deficiencyies
17
Unique D-Tags
CMS Certification Number 46D2257034
Address 12217 Lone Peak Pkwy, Ste 100, Draper, UT, 84020
City Draper
State UT
Zip Code84020
Phone(833) 765-5227

Citation History (3 surveys)

Survey - September 19, 2025

Survey Type: Standard

Survey Event ID: 13OX11

Deficiency Tags: D0000 D5400 D5403 D5423 D5425 D5427 D5800 D5821 D6128 D0000 D5400 D5403 D5423 D5425 D5427 D5800 D5821 D6128

Summary:

Summary Statement of Deficiencies D0000 The facility was found to be out of compliance with the conditions of the CLIA program. The following CONDITION LEVEL DEFICIENCIES were found to be out of compliance: _ D5400 - 42 CFR 493.1250, Condition: Analytic systems D5800 - 42 CFR 493.1290, Condition: Postanalytic Systems _ D5400 ANALYTIC SYSTEMS CFR(s): 493.1250 Each laboratory that performs nonwaived testing must meet the applicable analytic systems requirements in 493.1251 through 493.1283, unless HHS approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub.7), that provides equivalent quality testing. The laboratory must monitor and evaluate the overall quality of the analytic systems and correct identified problems as specified in 493.1289 for each specialty and subspecialty of testing performed. This CONDITION is not met as evidenced by: _ Based on surveyor record review and staff interviews, the laboratory failed to monitor and evaluate the overall quality of the analytic systems and correct identified problems by not including step by step instructions for manual integration of chromatogram peak area, pertinent literature references, and a description of the course of action to take if a test system becomes inoperable in its procedure (see D5403), by not properly establishing performance specifications for multiple assays (see D5423), by not determining calibration procedures based on establishment of performance specifications (see D5425), and by not retaining all validation run data of assay establishment studies for LC/MS/MS (see D5427) _ D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) (b) The procedure manual must include the following when applicable to the test Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 5 -- procedure: (b)(1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (b)(2) Microscopic examination, including the detection of inadequately prepared slides. (b)(3) Step-by- step performance of the procedure, including test calculations and interpretation of results. (b)(4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (b)(5) Calibration and calibration verification procedures. (b)(6) The reportable range for test results for the test system as established or verified in 493.1253. (b)(7) Control procedures. (b)(8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 10, 2024

Survey Type: Complaint

Survey Event ID: 7WVF11

Deficiency Tags: D0000

Summary:

Summary Statement of Deficiencies D0000 A CLIA complaint survey conducted on 07/10/2025, found the Rocky Mountain Laboratories laboratory located in Draper, Utah to be in substantial compliance with 42 CFR, Part 493; The Clinical Laboratory Improvement Amendments. The surveyor cited no deficiencies, and the laboratory has been recommended for recertification. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 25, 2023

Survey Type: Standard

Survey Event ID: 1ZJJ11

Deficiency Tags: D2015 D2015 D3027 D5217 D5415 D6103 D6168 D6171 D6171 D2009 D2009 D3027 D5217 D5403 D5403 D5415 D6103 D6168

Summary:

Summary Statement of Deficiencies D2009 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The individual testing or examining the samples and the laboratory director must attest to the routine integration of the samples into the patient workload using the laboratory's routine methods. This STANDARD is not met as evidenced by: Based on record review of proficiency testing performance evaluations and interview with the technical supervisor (TS), the laboratory failed to attest that proficiency testing (PT) samples were tested in the same manner as patient specimens for proficiency samples in 2023 for College of American Pathology (CAP) PT testing events 1 and 2 for bacteriology and virology. Findings include 1. A review of the proficiency testing performance evaluations on 10/25/23 revealed that the laboratory director or designee and testing personnel performing testing failed to sign the attestation statements for the CAP 2023 Microbiology - 1st and 2nd events and the CAP 2023 Virology - 1st and 2nd events. 2. In an interview on 10/25/23 at 1:55 PM, the TS confirmed that the laboratory director or designee and testing personnel performing testing failed to sign the attestation statements. D2015 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(5)(6) (5) The laboratory must document the handling, preparation, processing, examination, and each step in the testing and reporting of results for all proficiency testing samples. The laboratory must maintain a copy of all records, including a copy of the proficiency testing program report forms used by the laboratory to record proficiency testing results including the attestation statement provided by the PT program, signed by the analyst and the laboratory director, documenting that proficiency testing samples were tested in the same manner as patient specimens, for a minimum of two Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 5 -- years from the date of the proficiency testing event. (6) PT is required for only the test system, assay, or examination used as the primary method for patient testing during the PT event. This STANDARD is not met as evidenced by: Based on a review of Proficiency Testing (PT) documentation and an interview with the Technical Supervisor (TS), the laboratory failed to maintain documentation of each step in in the testing and reporting of results for proficiency testing samples the CAP 2023 Microbiology - 1st and 2nd events and the CAP 2023 Virology - 1st and 2nd events. Findings include: 1. Record review of PT documentation of the CAP 2023 Microbiology - 1st and 2nd events and the CAP 2023 Virology - 1st and 2nd events on 10/25/23 failed to produce signed attestation statements, instrument printouts, PT program report forms, and documentation of who handled, prepared, processed, ran, and resulted each step of the PT submissions, instrument printouts, and PT forms. 2. In an interview on 10/25/23 at 2:00 PM, the TS confirmed that the laboratory did not retain required PT documentation for CAP Virology and Microbiology 2023 events. D3027 RETENTION REQUIREMENTS CFR(s): 493.1105(a)(1) Test requisitions and authorizations. Retain records of test requisitions and test authorizations, including the patient's chart or medical record if used as the test requisition or authorization, for at least 2 years. This STANDARD is not met as evidenced by: Based on patient test record review and interview with the QA Manager, the laboratory failed to retain test requisitions for at least 2 years for samples received by the laboratory for one of five patient records reviewed. The laboratory performed approximately 810,000 tests annually. Findings include: 1. Review of patient test records on 10/25/2023 failed to include requisitions for one of five samples that were received and analyzed by the laboratory. 2. The QA Manager confirmed during interview on 10/25/2023 at approximately 4:00 PM, that test requisitions are not always retained for at least 2 years. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on Record review and interview with the Technical Supervisor (TS), the laboratory failed to twice annually evaluate the accuracy of analytes of molecular panels that were not included in subpart I since the laboratory began operation in April 2022. The laboratory performed approximately 300,000 molecular tests annually. Findings include: 1. Record review on 10/25/2023, revealed a lack of documentation to verify twice annually the accuracy of analytes not included in subpart I of molecular respiratory pathogens panel, urinary tract infection panel, gastrointestinal pathogen panel, sexually transmitted infections panel, wound infections panel, nail, fungal panel, and women's health panel. 2. In an interview with -- 2 of 5 -- the TS on 10/25/2023 at 2:20 PM, it was confirmed that the laboratory failed to twice annually evaluate the accuracy of analytes in molecular panels that were not included in subpart I. D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access